Eliem Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $151k | 22k | 6.85 |
| 2025-03-31 | $86k | 70k | 1.22 |
| 2024-12-31 | $126k | 70k | 1.80 |
| 2024-09-30 | $357k | 70k | 5.09 |
| 2024-06-30 | $122k | 17k | 7.11 |
| 2022-03-31 | $135k | 16k | 8.44 |
| 2021-12-31 | $181k | 17k | 10.51 |
| 2021-09-30 | $310k | 17k | 18.00 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management